ArticlePloS one2026
Exploring the role of resilience and quality of life in preoperative fear of cancer recurrence among patients with oral and maxillofacial cancer: A cross-sectional study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsFear of cancer recurrence (FCR) is a common concern among cancer survivors; however, its prevalence and determinants in patients with oral and maxillofacial cancers have not been thoroughly investigated. This study aimed to assess the severity of FCR and explore the relationships among resilience, quality of life (QoL), and FCR in preoperative oral and maxillofacial cancer patients.
methodsA cross-sectional survey was conducted in tertiary hospitals in China from March to July 2024. The study collected demographic and clinical data, the Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF), the 10-item Connor-Davidson Resilience Scale (CD-RISC-10), and the University of Washington Quality of Life Questionnaire (UW-QOL). Data analysis included descriptive statistics, independent samples t-tests, one-way ANOVA, and multiple linear regression analysis.
resultsThe study included 281 preoperative oral and maxillofacial cancer patients. The mean FCRI-SF score was 17.38 (SD = 4.73), with 85.1% of the participants exhibiting high FCR. Resilience, as measured by CD-RISC-10, had a mean score of 23.33 (SD = 3.85), whereas QoL, measured by the UW-QOL, had an average of 58.36 (SD = 8.61). Correlation analysis revealed significant associations among age, sex, first treatment, resilience, QoL, and FCR. Multiple linear regression revealed that QoL and sex were significant predictors of FCR, explaining 40.1% of the variance (P < 0.001). Higher QoL was associated with lower FCR, and males reported lower levels of FCR than females did. DISCUSSION: Preoperative oral and maxillofacial cancer patients experience elevated levels of FCR, which are influenced by various socio-demographic and clinical factors. These findings highlight the need for healthcare providers to develop targeted interventions and comprehensive support systems to address FCR effectively in this high-risk group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.